Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC
· Real-Time Price · USD
12.93
0.27 (2.13%)
At close: Aug 15, 2025, 3:59 PM
11.05
-14.54%
After-hours: Aug 15, 2025, 07:55 PM EDT
Benitec Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Net Income | -9.35M | -7.36M | -5.06M | -4.72M | -4.28M | -6.8M | -5.95M | -4.66M | -4.4M | -5.41M | -5.09M | -5.07M | -3.27M | -4.82M | -5.04M | -4M | -3.91M | -3.25M | -2.72M |
Depreciation & Amortization | 106K | 81K | 91K | 91K | 90K | 80K | 82K | 84K | 93K | 102K | 102K | 63K | 114K | 113K | 102K | 102K | 115K | 115K | 92K |
Stock-Based Compensation | 2.6M | 943K | 435K | 454K | 192K | 93K | 91K | 127K | 71K | -48K | 302K | 168K | 192K | 239K | 271K | 279K | 235K | 82K | 38K |
Other Working Capital | 659K | -606K | -53K | -661.83K | 142.51K | 123.41K | 638K | 356K | 200K | 60.03K | 147K | 52K | -459K | 1.1M | 412K | -1.52M | 1.57M | -270K | 228K |
Other Non-Cash Items | 2.91M | -764K | n/a | -5.8K | 2.6M | 1K | 1.2M | -1K | 4K | 3K | -3K | 837.17K | 5K | 23K | -18K | -19K | 4K | -1K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 659K | -606K | -53K | 882K | -2.16M | 1.26M | 1.2M | 356K | 200K | -489K | 647K | -19K | -459K | 1.1M | 412K | -1.52M | 1.57M | -270K | 228K |
Operating Cash Flow | -3.09M | -7.7M | -4.59M | -3.29M | -6.24M | -5.37M | -4.58M | -4.09M | -4.03M | -5.84M | -4.04M | -4.86M | -3.42M | -3.34M | -4.28M | -5.16M | -1.99M | -3.33M | -2.36M |
Capital Expenditures | -6K | -12K | n/a | -564.34 | -179.42K | n/a | n/a | -1K | n/a | n/a | n/a | -18.83K | n/a | n/a | n/a | 141K | -15K | -174K | -173K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 12K | -12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -6K | -12K | n/a | -565.04 | -179.42K | n/a | n/a | -1K | n/a | 310.01K | n/a | -13K | n/a | n/a | n/a | 141K | -15K | -174K | -173K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 37.48M | -2K | 21.66M | -2.93M | 154.88K | 39K | -2.96M | 17.88M | n/a | -310.01K | -1.87M | n/a | n/a | n/a | n/a | -1.58M | n/a | -1.64M | n/a |
Financial Cash Flow | 28.41M | 17.87M | 21.66M | 40.07M | 154.88K | 39K | 27.92M | -264.58K | n/a | -310.01K | 16.02M | n/a | n/a | n/a | n/a | 12.67M | 3K | 9.85M | n/a |
Net Cash Flow | 25.3M | 10.44M | 16.98M | 36.77M | -6.23M | -5.49M | 23.39M | -4.08M | -3.99M | -6M | 12.47M | -4.55M | -3.7M | -3.4M | -4.04M | 7.78M | -2.02M | 6.56M | -2.35M |
Free Cash Flow | -3.09M | -7.71M | -4.59M | -3.29M | -6.42M | -5.37M | -4.58M | -4.1M | -4.03M | -5.84M | -4.04M | -4.87M | -3.42M | -3.34M | -4.28M | -5.02M | -2M | -3.5M | -2.53M |